Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump )
Also on site :
- Über das Spiel hinaus: Haier Vision für Jugend und Nachhaltigkeit
- The Three States Driving America’s Solar Boom
- Scandinavia’s Nuclear Waste Revolution